Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer
Objectives: Minimally invasive surgery (MIS) is a limited treatment option for early-stage ovarian cancer. The National Comprehensive Cancer Network® guidelines that salpingo-oophorectomy should be performed with every effort to keep an encapsulated mass intact during removal. We aimed to investigat...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Gynecology and Minimally Invasive Therapy |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/gmit.gmit_77_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850053851685584896 |
|---|---|
| author | Kohei Omatsu Chyi-Long Lee Kuan-Gen Huang |
| author_facet | Kohei Omatsu Chyi-Long Lee Kuan-Gen Huang |
| author_sort | Kohei Omatsu |
| collection | DOAJ |
| description | Objectives:
Minimally invasive surgery (MIS) is a limited treatment option for early-stage ovarian cancer. The National Comprehensive Cancer Network® guidelines that salpingo-oophorectomy should be performed with every effort to keep an encapsulated mass intact during removal. We aimed to investigate whether, if tumor rupture was controlled, patients’ oncological outcomes for Stage I ovarian cancer would not be worse in MIS. An endobag was prepared and used to prevent the ovarian cancer cells from spilling into the peritoneal cavity. We report a recent 10-year clinical outcome of MIS for ovarian cancer by oncological endoscopists in gynecology.
Materials and Methods:
We retrospectively collected clinical data from an electric chart. Collective clinical data included age, body mass index (BMI), operative time (OT), estimated blood loss (EBL), intraoperative rupture (IR), duration of hospital stay (HS), time from the operation date to the first infusion of chemotherapy (TOFC), disease-free survival (DFS), and overall survival (OS) at 5 years. The data were statistically analyzed using EZR.
Results:
The median age, BMI, OT, EBL, IR, HS, TOFC, and DFS were 50 years, 23.9 kg/m2, 363 min, 100 mL, 65 (98%) patients, 7 days, 15 days, and 43.4 months, respectively. The OS was 98%. The data were consistent with those from the past 10 years, except for a tendency toward an increasing trend in the proportion of ruptured tumors during surgery.
Conclusion:
Tumor rupture within the prepared endobag during MIS did not affect the oncological outcomes of early-stage ovarian cancer. |
| format | Article |
| id | doaj-art-8bd4d4476c5146dabf2e023d80f69e2f |
| institution | DOAJ |
| issn | 2213-3070 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Gynecology and Minimally Invasive Therapy |
| spelling | doaj-art-8bd4d4476c5146dabf2e023d80f69e2f2025-08-20T02:52:26ZengWolters Kluwer Medknow PublicationsGynecology and Minimally Invasive Therapy2213-30702025-01-01141667110.4103/gmit.gmit_77_24Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian CancerKohei OmatsuChyi-Long LeeKuan-Gen HuangObjectives: Minimally invasive surgery (MIS) is a limited treatment option for early-stage ovarian cancer. The National Comprehensive Cancer Network® guidelines that salpingo-oophorectomy should be performed with every effort to keep an encapsulated mass intact during removal. We aimed to investigate whether, if tumor rupture was controlled, patients’ oncological outcomes for Stage I ovarian cancer would not be worse in MIS. An endobag was prepared and used to prevent the ovarian cancer cells from spilling into the peritoneal cavity. We report a recent 10-year clinical outcome of MIS for ovarian cancer by oncological endoscopists in gynecology. Materials and Methods: We retrospectively collected clinical data from an electric chart. Collective clinical data included age, body mass index (BMI), operative time (OT), estimated blood loss (EBL), intraoperative rupture (IR), duration of hospital stay (HS), time from the operation date to the first infusion of chemotherapy (TOFC), disease-free survival (DFS), and overall survival (OS) at 5 years. The data were statistically analyzed using EZR. Results: The median age, BMI, OT, EBL, IR, HS, TOFC, and DFS were 50 years, 23.9 kg/m2, 363 min, 100 mL, 65 (98%) patients, 7 days, 15 days, and 43.4 months, respectively. The OS was 98%. The data were consistent with those from the past 10 years, except for a tendency toward an increasing trend in the proportion of ruptured tumors during surgery. Conclusion: Tumor rupture within the prepared endobag during MIS did not affect the oncological outcomes of early-stage ovarian cancer.https://journals.lww.com/10.4103/gmit.gmit_77_24frozen sectionminimally invasive surgeryprognosisstage i epithelial ovarian cancer |
| spellingShingle | Kohei Omatsu Chyi-Long Lee Kuan-Gen Huang Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer Gynecology and Minimally Invasive Therapy frozen section minimally invasive surgery prognosis stage i epithelial ovarian cancer |
| title | Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer |
| title_full | Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer |
| title_fullStr | Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer |
| title_full_unstemmed | Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer |
| title_short | Improvement of Prognostic Outcome in Minimally Invasive Surgery for Stage I Epithelial Ovarian Cancer |
| title_sort | improvement of prognostic outcome in minimally invasive surgery for stage i epithelial ovarian cancer |
| topic | frozen section minimally invasive surgery prognosis stage i epithelial ovarian cancer |
| url | https://journals.lww.com/10.4103/gmit.gmit_77_24 |
| work_keys_str_mv | AT koheiomatsu improvementofprognosticoutcomeinminimallyinvasivesurgeryforstageiepithelialovariancancer AT chyilonglee improvementofprognosticoutcomeinminimallyinvasivesurgeryforstageiepithelialovariancancer AT kuangenhuang improvementofprognosticoutcomeinminimallyinvasivesurgeryforstageiepithelialovariancancer |